Vtv Therapeutics Stock Today
| VTVT Stock | USD 25.50 0.52 2.08% |
Performance14 of 100
| Odds Of DistressLess than 8
|
VTv Therapeutics is selling for under 25.50 as of the 25th of April 2024; that is 2.08% increase since the beginning of the trading day. The stock's last reported lowest price was 24.01. VTv Therapeutics has only a 8 % chance of going through financial distress over the next few years and had a good performance during the last 90 days. Equity ratings for vTv Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 30th of July 2015 | Category Healthcare | Classification Health Care |
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company was incorporated in 2015 and is headquartered in High Point, North Carolina. vTv Therapeutics Inc. The company has 2.43 M outstanding shares of which 32.24 K shares are at this time shorted by private and institutional investors with about 0.18 trading days to cover. More on vTv Therapeutics
Moving together with VTv Stock
| 0.75 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.85 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.65 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.72 | CGC | Canopy Growth Corp Trending | PairCorr |
Moving against VTv Stock
| 0.66 | GILD | Gilead Sciences Earnings Call Today | PairCorr |
| 0.64 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
VTv Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. VTv Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding VTv Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO | Paul MSc | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Pharmaceutical Products (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Pharmaceutical Products, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering VTv Therapeutics report their recommendations after researching VTv Therapeutics' financial statements, talking to executives and customers, or listening in on VTv Therapeutics' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering vTv Therapeutics. The VTv consensus assessment is calculated by taking the average forecast from all of the analysts covering VTv Therapeutics. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to VTv Therapeutics' liquidity, profitability, solvency, and operating efficiency, vTv Therapeutics is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of vTv Therapeutics is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VTv Therapeutics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to VTv Therapeutics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand VTv Therapeutics' financial leverage. It provides some insight into what part of VTv Therapeutics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
vTv Therapeutics (VTVT) is traded on NASDAQ Exchange in USA. It is located in 3980 Premier Drive, High Point, NC, United States, 27265 and employs 16 people. VTv Therapeutics is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 58.4 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate VTv Therapeutics's market, we take the total number of its shares issued and multiply it by VTv Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. vTv Therapeutics conducts business under Biotechnology sector and is part of Health Care industry. The entity has 2.43 M outstanding shares of which 32.24 K shares are at this time shorted by private and institutional investors with about 0.18 trading days to cover.
vTv Therapeutics currently holds about 17.95 M in cash with (18.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22.
Check VTv Therapeutics Probability Of Bankruptcy
Ownership AllocationThe market capitalization of VTv Therapeutics is $58.4 Million. vTv Therapeutics maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check VTv Ownership Details
VTv Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of VTv Therapeutics jumping above the current price in 90 days from now is about 9.86%. The vTv Therapeutics probability density function shows the probability of VTv Therapeutics stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.2208. This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, VTv Therapeutics will likely underperform. In addition to that, vTv Therapeutics has an alpha of 2.219, implying that it can generate a 2.22 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of VTv Therapeutics to move above the current price in 90 days from now is about 9.86 (This vTv Therapeutics probability density function shows the probability of VTv Stock to fall within a particular range of prices over 90 days) .
VTv Stock Institutional Holders
Institutional Holdings refers to the ownership stake in VTv Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of VTv Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing VTv Therapeutics' value.| Instituion | Recorded On | Shares | |
| Cornerstone Planning Group Llc | 2023-12-31 | 19.0 | |
| Sunbelt Securities | 2023-12-31 | 15.0 | |
| Jpmorgan Chase & Co | 2023-12-31 | 1.0 | |
| Bank Of America Corp | 2023-12-31 | 1.0 | |
| State Street Corporation | 2023-12-31 | 0.0 | |
| Susquehanna International Group, Llp | 2023-12-31 | 0.0 | |
| Northern Trust Corp | 2023-12-31 | 0.0 | |
| Millennium Management Llc | 2023-12-31 | 0.0 | |
| Bnp Paribas Arbitrage, Sa | 2023-12-31 | 0.0 | |
| Pathstone Family Office, Llc | 2023-09-30 | 242.9 K | |
| Samsara Biocapital, Llc | 2023-12-31 | 40.9 K |
VTv Therapeutics Historical Income Statement
vTv Therapeutics Income Statement is one of the three primary financial statements used for reporting VTv's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of vTv Therapeutics revenue and expense. VTv Therapeutics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, VTv Therapeutics' Other Operating Expenses is comparatively stable compared to the past year. Research Development is likely to gain to about 18 M in 2024, whereas Selling General Administrative is likely to drop slightly above 11.5 M in 2024. View More FundamentalsVTv Stock Against Markets
Picking the right benchmark for VTv Therapeutics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in VTv Therapeutics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for VTv Therapeutics is critical whether you are bullish or bearish towards vTv Therapeutics at a given time. Please also check how VTv Therapeutics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in VTv Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
VTv Therapeutics Corporate Directors
VTv Therapeutics corporate directors refer to members of a VTv Therapeutics board of directors. The board of directors generally takes responsibility for the VTv Therapeutics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of VTv Therapeutics' board members must vote for the resolution. The VTv Therapeutics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Steven Cohen | Director Nominee | Profile | |
| Paul Savas | Director | Profile | |
| Craig Parker | Independent Director Nominee | Profile | |
| Richard Nelson | Executive Director | Profile |
How to buy VTv Stock?
Before investing in VTv Therapeutics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in VTv Therapeutics. To buy VTv Therapeutics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of VTv Therapeutics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase VTv Therapeutics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located vTv Therapeutics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased vTv Therapeutics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as vTv Therapeutics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.
Already Invested in vTv Therapeutics?
The danger of trading vTv Therapeutics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of VTv Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than VTv Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile vTv Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether vTv Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if VTv Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Vtv Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Vtv Therapeutics Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in vTv Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for VTv Stock analysis
When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stocks Directory Find actively traded stocks across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance |
Is VTv Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VTv Therapeutics. If investors know VTv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VTv Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.71) | Revenue Per Share 0.004 | Return On Assets (0.72) | Return On Equity (49.78) |
The market value of vTv Therapeutics is measured differently than its book value, which is the value of VTv that is recorded on the company's balance sheet. Investors also form their own opinion of VTv Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is VTv Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VTv Therapeutics' market value can be influenced by many factors that don't directly affect VTv Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VTv Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if VTv Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VTv Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.